{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:44:41Z","timestamp":1785879881958,"version":"3.56.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001734","name":"K\u00f8benhavns Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003491","name":"Herlev Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002918","name":"Gentofte Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002918","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032682","name":"Department of Clinical Biochemistry, Aarhus University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032682","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejim.2026.106834","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:34:40Z","timestamp":1773664480000},"page":"106834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lifestyle characteristics and plasma biomarkers for risk of MASLD differ by sex in the general population"],"prefix":"10.1016","volume":"149","author":[{"given":"L\u00e6rke Kristine","family":"Kyhl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f8rge Gr\u00f8nne","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tybj\u00e6rg-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Huy Cuong","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen Tobias","family":"K\u00fchl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9742-1554","authenticated-orcid":false,"given":"Klaus Fuglsang","family":"Kofoed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3509-9560","authenticated-orcid":false,"given":"Sune Fallgaard","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejim.2026.106834_bib0001","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.ejim.2026.106834_bib0002","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/j.ejim.2026.106834_bib0003","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N Engl J Med"},{"issue":"10250","key":"10.1016\/j.ejim.2026.106834_bib0004","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)31561-0","article-title":"Sex and gender: modifiers of health, disease, and medicine","volume":"396","author":"Mauvais-Jarvis","year":"2020","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ejim.2026.106834_bib0005","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.ejim.2026.106834_bib0006","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.ejim.2026.106834_bib0007","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/ehjci\/jev337","article-title":"Normal values of left ventricular mass and cardiac chamber volumes assessed by 320-detector computed tomography angiography in the Copenhagen General Population Study","volume":"17","author":"Fuchs","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"15","key":"10.1016\/j.ejim.2026.106834_bib0008","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/eurheartj\/ehab087","article-title":"The physical activity paradox in cardiovascular disease and all-cause mortality: the contemporary Copenhagen General Population Study with 104 046 adults","volume":"42","author":"Holtermann","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ejim.2026.106834_bib0009","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/eurheartj\/ehx662","article-title":"Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: mendelian randomization and meta-analysis of 279 013 individuals","volume":"39","author":"Lauridsen","year":"2018","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ejim.2026.106834_bib0010","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.ejim.2026.106834_bib0011","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00330-011-2349-2","article-title":"Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis","volume":"22","author":"Pickhardt","year":"2012","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.ejim.2026.106834_bib0012","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2214\/AJR.06.0992","article-title":"Comparison of CT methods for determining the fat content of the liver","volume":"188","author":"Kodama","year":"2007","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"10.1016\/j.ejim.2026.106834_bib0013","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/liv.14600","article-title":"The association of non-alcoholic fatty liver disease and cardiac structure and function-Framingham Heart Study","volume":"40","author":"Chiu","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2026.106834_bib0014","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.atherosclerosis.2020.03.009","article-title":"Relationship of fibroblast growth factor 21 levels with inflammation, lipoproteins and non-alcoholic fatty liver disease","volume":"299","author":"Tucker","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejim.2026.106834_bib0015","unstructured":"Yajima Y. Fau - Narui T., Narui T. Fau - Ishii M., Ishii M. Fau - Abe R., et al. Computed tomography in the diagnosis of fatty liver: total lipid content and computed tomography number. (0040-8727 (Print))."},{"key":"10.1016\/j.ejim.2026.106834_bib0016","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejim.2024.01.013","article-title":"Non-invasive testing and risk-stratification in patients with MASLD","volume":"122","author":"Zoncap\u00e8","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"3","key":"10.1016\/j.ejim.2026.106834_bib0017","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1148\/radiol.10101233","article-title":"Biopsy-proven nonsteatotic liver in adults: estimation of reference range for difference in attenuation between the liver and the spleen at nonenhanced CT","volume":"258","author":"Park","year":"2011","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ejim.2026.106834_bib0018","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/HYPERTENSIONAHA.109.130005","article-title":"Does greater adiposity increase blood pressure and hypertension risk?","volume":"54","author":"Timpson","year":"2009","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.ejim.2026.106834_bib0019","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/HYPERTENSIONAHA.117.09411","article-title":"Vitamin D, hypertension, and ischemic stroke in 116 655 individuals from the general population","volume":"70","author":"Afzal","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2026.106834_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2023.05.015","article-title":"High fat in blood and body and increased risk of clinically diagnosed non-alcoholic fatty liver disease in 105,981 individuals","volume":"376","author":"Kyhl","year":"2023","journal-title":"Atherosclerosis"},{"issue":"24","key":"10.1016\/j.ejim.2026.106834_bib0021","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/eurheartj\/ehaa172","article-title":"Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: mendelian randomization in the Copenhagen general population study","volume":"41","author":"Kaltoft","year":"2020","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ejim.2026.106834_bib0022","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s10654-021-00763-3","article-title":"Risk of ulcerative colitis and Crohn's disease in smokers lacks causal evidence","volume":"37","author":"Pedersen","year":"2022","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"10.1016\/j.ejim.2026.106834_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217398","article-title":"Physical activity and risk of instant and 28-day case-fatality in myocardial infarction","volume":"14","author":"Peytz","year":"2019","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ejim.2026.106834_bib0024","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacc.2021.01.027","article-title":"Apolipoprotein B and non-HDL cholesterol better reflect residual risk than LDL cholesterol in statin-treated patients","volume":"77","author":"Johannesen","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"34","key":"10.1016\/j.ejim.2026.106834_bib0025","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1093\/eurheartj\/ehab705","article-title":"Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study","volume":"43","author":"Wadstr\u00f6m","year":"2021","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.ejim.2026.106834_bib0026","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.jacc.2012.02.043","article-title":"Nonfasting glucose, ischemic heart disease, and myocardial infarction: a mendelian randomization study","volume":"59","author":"Benn","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.ejim.2026.106834_bib0027","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa0707402","article-title":"Genetically elevated C-reactive protein and ischemic vascular disease","volume":"359","author":"Zacho","year":"2008","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.ejim.2026.106834_bib0028","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1097\/QAD.0000000000001954","article-title":"No evidence of increased risk of thyroid dysfunction in well treated people living with HIV","volume":"32","author":"Harsl\u00f8f","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.ejim.2026.106834_bib0029","series-title":"Waist circumference and waist-hip ratio","year":"2008"},{"issue":"1","key":"10.1016\/j.ejim.2026.106834_bib0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12933-023-01921-5","article-title":"Triglycerides and risk of cardiovascular events in statin-treated patients with newly diagnosed type 2 diabetes: a Danish cohort study","volume":"22","author":"Kristensen","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1016\/j.ejim.2026.106834_bib0031","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ejim.2026.106834_bib0032","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ejim.2026.106834_bib0033","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2026.106834_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1015919","article-title":"Association between smoking cessation and non-alcoholic fatty liver disease using NAFLD liver fat score","volume":"11","author":"Jang","year":"2023","journal-title":"Front Public Health"},{"issue":"4","key":"10.1016\/j.ejim.2026.106834_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195147","article-title":"Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: a longitudinal cohort study","volume":"13","author":"Okamoto","year":"2018","journal-title":"PLoS One"},{"issue":"7932","key":"10.1016\/j.ejim.2026.106834_bib0036","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41586-022-05299-4","article-title":"Gut bacteria alleviate smoking-related NASH by degrading gut nicotine","volume":"610","author":"Chen","year":"2022","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.ejim.2026.106834_bib0037","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/MEG.0b013e32834b8d52","article-title":"Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase","volume":"23","author":"L\u00f3pez-Su\u00e1rez","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.ejim.2026.106834_bib0038","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/HYPERTENSIONAHA.119.13419","article-title":"Nonalcoholic fatty liver disease","volume":"75","author":"Zhao","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2026.106834_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.942753","article-title":"Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality","volume":"9","author":"Ng","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.ejim.2026.106834_bib0040","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jhep.2024.01.014","article-title":"Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease","volume":"80","author":"Younossi","year":"2024","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.ejim.2026.106834_bib0041","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1038\/s41598-023-31686-6","article-title":"Associations of physical activity domains and muscle strength exercise with non-alcoholic fatty liver disease: a nation-wide cohort study","volume":"13","author":"Park","year":"2023","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.ejim.2026.106834_bib0042","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/hep.22525","article-title":"Role of leisure-time physical activity in nonalcoholic fatty liver disease: a population-based study","volume":"48","author":"Zelber-Sagi","year":"2008","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.ejim.2026.106834_bib0043","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jhepr.2019.10.008","article-title":"Lifestyle modification in NAFLD\/NASH: facts and figures","volume":"1","author":"Hallsworth","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.ejim.2026.106834_bib0044","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000042","article-title":"Role of fatty liver index and metabolic factors in the prediction of nonalcoholic fatty liver disease in a lean population receiving health checkup","volume":"10","author":"Hsu","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.ejim.2026.106834_bib0045","doi-asserted-by":"crossref","unstructured":"Frey S., Patouraux S., Debs T., Gugenheim J., Anty R., Iannelli A. Prevalence of NASH\/NAFLD in people with obesity who are currently classified as metabolically healthy. Surgery for obesity and related diseases. 2020. doi: https:\/\/doi.org\/10.1016\/j.soard.2020.07.009.","DOI":"10.1016\/j.soard.2020.07.009"},{"issue":"4","key":"10.1016\/j.ejim.2026.106834_bib0046","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz265","article-title":"Low high-density lipoprotein cholesterol to monitor long-term average increased triglycerides","volume":"105","author":"Langsted","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ejim.2026.106834_bib0047","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12944-021-01573-y","article-title":"Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study","volume":"20","author":"Zou","year":"2021","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.ejim.2026.106834_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1098078","article-title":"Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease","volume":"14","author":"Cheng","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.ejim.2026.106834_bib0049","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000514848","article-title":"Triglycerides mediate body mass index and nonalcoholic fatty liver disease: a population-based study","volume":"14","author":"Xing","year":"2021","journal-title":"Obes Facts"},{"issue":"2","key":"10.1016\/j.ejim.2026.106834_bib0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4291\/wjgp.v8.i2.11","article-title":"Nonalcoholic fatty liver disease: diagnostic biomarkers","volume":"8","author":"Hadizadeh","year":"2017","journal-title":"World J Gastrointest Pathophysiol"},{"issue":"3","key":"10.1016\/j.ejim.2026.106834_bib0051","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jhep.2010.12.017","article-title":"C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients","volume":"55","author":"Zimmermann","year":"2011","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.ejim.2026.106834_bib0052","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1007\/s10620-013-2743-5","article-title":"Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"58","author":"Stepanova","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.ejim.2026.106834_bib0053","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.ejim.2026.106834_bib0054","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","article-title":"A position statement on NAFLD\/NASH based on the EASL 2009 special conference","volume":"53","author":"Ratziu","year":"2010","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.ejim.2026.106834_bib0055","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jacl.2015.12.026","article-title":"Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol","volume":"10","author":"Wu","year":"2016","journal-title":"J Clin Lipidol"},{"issue":"5","key":"10.1016\/j.ejim.2026.106834_bib0056","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/nu5051544","article-title":"Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease","volume":"5","author":"Gaggini","year":"2013","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.ejim.2026.106834_bib0057","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1089\/thy.2018.0257","article-title":"Association between primary hypothyroidism and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"28","author":"Mantovani","year":"2018","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.ejim.2026.106834_bib0058","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ejim.2026.106834_bib0059","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/hep.27869","article-title":"Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study","volume":"62","author":"VanWagner","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.ejim.2026.106834_bib0060","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/ATVBAHA.114.305200","article-title":"Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study","volume":"35","author":"Long","year":"2015","journal-title":"Arter Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.ejim.2026.106834_bib0061","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1620\/tjem.136.337","article-title":"Computed tomography in the diagnosis of fatty liver: total lipid content and computed tomography number","volume":"136","author":"Yajima","year":"1982","journal-title":"Tohoku J Exp Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526001391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526001391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:50:52Z","timestamp":1785876652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620526001391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":61,"alternative-id":["S0953620526001391"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106834","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lifestyle characteristics and plasma biomarkers for risk of MASLD differ by sex in the general population","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106834","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}],"article-number":"106834"}}